Results 141 to 150 of about 67,411 (205)

Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes. [PDF]

Cancer Med
Zhou H, Chen L, Lu Q, Wu H, Jiang K, Xu F, Wang S.   +6 more
europepmc   +1 more source

Adjuvant chemotherapy in elderly colon cancer patients: when less may be more. [PDF]

J Gastrointest Oncol
Eslinger C, Sonbol MB.
europepmc   +1 more source

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy. [PDF]

Breast Cancer Res Treat
Tavares GM, Ramalho SOB, da Silva LR, Telles GD, de Paiva Silva GR, Torresan RZ, Derchain SFM.   +6 more
europepmc   +1 more source

Severe Hyperammonemic Encephalopathy Associated With Gastrointestinal Bleeding During Capecitabine and Oxaliplatin Chemotherapy in a Patient With Rectal Adenocarcinoma. [PDF]

Cureus
Komatsu T, Agrawal VA.
europepmc   +1 more source

Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review. [PDF]

Curr Oncol Rep
Iimura Y, Kuroda S.
europepmc   +1 more source

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study. [PDF]

BMC Med
Liu J, Jiang M, Zhang M, Zhou S, Li M, Shi X, Li L, Yang X, Li P, Tian M, Ma F, Xu B, Li Q.   +12 more
europepmc   +1 more source

Prevalence, Clinical Characteristics, and Factors Associated with Capecitabine-Induced Hand-Foot Syndrome in Patients with Cancer: Evidence from Sudan. [PDF]

Drugs Real World Outcomes
Obeid OK, Yousef BA, Hamadalneel YB, Mustafa MA, Mahmoud AA, Elhag EAA.   +5 more
europepmc   +1 more source

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Chiddarwar T, Blaes A, Kuntz K.
europepmc   +1 more source

Adherence to oral antineoplastic agents, an overview and meta-analysis. [PDF]

Oncologist
Mourath D, Fohlin H.
europepmc   +1 more source

Treatment of HER2-Positive Brain Metastasis from Cervical Cancer Using Multimodal Therapy Including Pyrotinib: A Case Report. [PDF]

Int J Womens Health
Chen Y, Wen T, Wen X, Lai Z.
europepmc   +1 more source